Search Results - "Somonova, O."

Diagnostic levels of sepsis biomarkers in children with oncological diseases by Golovnya, E G, Kharitidi, T Yu, Sotnikov, A V, Somonova, O V, Kushlinskii, N E

“…The data on the diagnostic levels of sepsis markers in blood plasma in 117 patients with oncological diseases at the age from 1 to 18 years are presented. The…”
Get more information

Use of 'Korona' cava filter in oncological patients by Cherkasov, V A, Dolgushin, B I, Andreev, Iu G, Somonova, O V

“…Using the 'Korona' cava filter in a total of 1345 oncological patients revealed regularity of a change in the shape of the inferior vena cava at the level of…”
Get more information

Prevention and treatment of thrombosis in cancer and oncohematological patients by Somonova, O. V., Elizarova, A. L., Davydova, T. V.

“…The purpose of the review is to highlight the current possibilities for the prevention and treatment of venous thrombotic complications in patients with…”
Get full text

Development of strategic approaches to modern diagnosis of anemic syndrome in patients with breast cancer. by Blindar, V N, Zubrikhina, G N, Davydova, T V, Somonova, O V, Elizarova, A L, Dobrovolskaya, M M, Kharitidi, T Yu, Lyubimova, N V, Kushlinsky, N E, Bobryshev, A A, Kononenko, I B, Snegovoy, A V

“…A study of the clinical analysis of blood and major metabolites of ferrokinetics in 107 breast cancer patients before treatment was conducted. In 31 (28.9%)…”
Get more information

T015 Fibrin-monomer in the diagnosis of thrombotic complications in oncology by Davydova, T., Elizarova, A., Somonova, O.

Get full text

DISSEMINATED INTRAVASCULAR COAGULATION SYNDROME IN SURGICAL TREATMENT OF PATIENTS WITH LIVER MALIGNANCIES by Somonova, O. V., Elizarova, A. L., Matveeva, I. I.

“…Rationale: Extended resections or extended lobectomies are the most common types of surgical interventions in patients with liver malignancies, and they are…”
Get full text

The role of platelets in inflammation and immunity by Sviridova, S. P., Somonova, O. V., Kashiya, Sh. R., Obukhova, O. A., Sotnikov, A. V.

“…In recent decades, significant progress has been made in understanding the mechanisms of platelet function and platelet hemostasis correction. Platelets are…”
Get full text

The prospects for using bemiparin in prophylaxis and treatment of thromboses in oncology by O. V. Somonova, A. L. Elizarova, Yu. A. Nesterova, N. N. Borisenko, U. A. Kornyushenko

“…Oncological patients have a high risk of thrombotic complications, which worsen the outcomes of antitumor treatment and is one of the leading causes of death…”
Get full text

PO-53 Phase II study of low molecular weight heparin (LMWH) in combination with immunotherapy in metastatic renal cell carcinoma patients by Tsimafeyeu, I, Madzhuga, A, Demidov, L, Somonova, O, Yelizarova, A

Get full text

PO-65 Is abnormal coagulation a possible prognostic factor for efficacy of immunotherapy in metastatic renal cell carcinoma patients? by Madzhuga, A, Tsimafeyeu, I, Demidov, L, Somonova, O, Yelizarova, A

Get full text

T014 The significance of the study of detoxification efficiency of serum albumin for early diagnosis and monitoring of purulent-septic complications in cancer patients by Davydova, T., Borisenko, N., Pluzhnikova, N., Sytov, A., Somonova, O., Elizarova, A., Kornyushenko, U.

Get full text

542 POSTER Abnormal coagulation as prognostic factor to impact on efficacy of immunotherapy in metastatic renal cell carcinoma patients by Tsimafeyeu, I, Madzhuga, A, Demidov, L, Somonova, O, Yelizarova, A, Kharkevich, G

Get full text

The clinical value of D-dimer in the diagnosis and treatment of thromboembolic complications and DIC syndrome in cancer patients by Madzhuga, A V, Somonova, O V, Elizarova, A L, Sviridova, S P, Zubrikhin, G N

“…The content of D-dimer was studied in 130 patients with cancer at various sites. Twenty-five patients were diagnosed as having pulmonary thromboembolism (PTE),…”
Get more information

The disorders of hemostasis and their prevention with low-molecular heparins in oncological patients by Somonova, O V, Kushlinskiĭ, N E

“…The patients with malignant neoplasms are subjected to high risk of development of venous and arterial thromboembolic disease. The development of thrombosis…”
Get more information

Low molecular weight heparin (LMWH) increases the efficacy of immunotherapy in metastatic renal cell carcinoma patients with abnormal coagulation by Tsimafeyeu, I., Madzhuga, A., Demidov, L., Somonova, O., Kharkevich, G., Yelizarova, A., Petenko, N.

“…Abstract only 15591 Background: Antitumor effects of LMWH are unclear. Heparin can bind with fibroblast-growth factor, other heparine-binding angiogenic…”
Get full text

The use of low molecular weight heparin Enixum® in the prevention and treatment of thrombosis in oncology by O V Somonova, A L Elizarova, I I Matveeva

“…Thromboembolic complications often develop in patients with various forms of malignant neoplasms, and the occurrence of thromboses complicates antitumor…”
Get full text

Determination of anti-Xa activity in cancer patients by Somonova, O V, Madzhuga, A V, Elizarova, A L, Zubrikhina, G N

“…Low molecular-weight heparins (clexan, fraxiparin, fragmin) were used in cancer patients to prevent hemostatic system disorders and related complications. The…”
Get more information

Low molecular-weight heparin (clexane) in the prevention of thrombotic events in patients with malignancies by Somonova, O V, Madzhuga, A V, Elizarova, A L, Sel'chuk, V Iu, Zubrikhina, G N, Bokhian, A Iu

“…The basic links of the hemostatic system and the markers of intravascular thrombogenesis were studied, by using an automatic STA Compact analyzer in 80…”
Get more information

Hemostasis disorders in cancer patients with massive intraoperative blood loss by Madzhuga, A V, Somonova, O V, Elizarova, A L, Sviridova, S P, Mazurina, O G, Kashiia, Sh R

“…The hemostasis system was examined before, during, and after surgery in 130 patients with blood loss from 50 to more than 200% total circulatory volume. Blood…”
Get more information

Intraoperative infusion-transfusion therapy in pediatric surgical oncology by Saltanov, A I, Baĭkova, V N, Illarionov, Iu V, Madzhuga, A V, Matinian, N V, Ordukhanian, Z S, Somonova, O V

“…Modern concept of intraoperative blood loss compensation differs crucially from the old rule to compensate the blood loss by donor blood in the same volume,…”
Get more information